ICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.

Stampa/Media: Press/Media

Periodo25 mar 2020

Media coverage

1

Media coverage

  • TitoloICMR approval: India okays use of FDC Kaletra to treat Covid; Hospitalised adult patients with laboratory confirmed SARS CoV-2 infection can give written informed consent to receive the treatment for 14 days.
    Nome del media/mezzo di comunicazioneThe Financial Express
    PaeseIndia
    Data25/03/20
    PersoneNivedita Gupta